Ozone-oxygen therapy has been studied in peer-reviewed literature across a range of clinical applications, including: M.S., Stroke, Sudden Hearing Loss, Diabetes, Osteoarthritis, Neuropathic Pain, Intervertebral Disc Hernia, Digital Ulcers in Systemic Sclerosis, and CIPN. Ozone therapy is a complementary modality — intended for use alongside conventional medical treatment.

HAB Herrmann Medozon devices are notified to the Medsafe Web Assisted Notification of Devices (WAND) database as required under the Medicines (Database of Medical Devices) Regulations 2003. All therapeutic product advertising by practitioners must comply with applicable New Zealand regulations.

HAB Herrmann devices are CE certified Class IIb medical devices, manufactured in Germany to ISO 9001, ISO 14001 and OHSAS 18001 standards. With over 40 years of ozone device manufacturing experience, HAB supplies hospitals, clinics and health centres worldwide.

Ozone-oxygen therapy is a complementary medical application, used alongside conventional medicine. As a practitioner-only modality, it can broaden your clinical offering — with treatment frequency varying depending on the patient and clinical indication.